Detalhe da pesquisa
1.
Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma.
Blood
; 139(26): 3732-3736, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436328
2.
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
Dermatol Ther
; 35(7): e15538, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477952
3.
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication.
J Am Acad Dermatol
; 84(3): 587-595, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352267
4.
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.
J Am Acad Dermatol
; 84(3): 597-604, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352268
5.
Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.
Adv Exp Med Biol
; 1290: 111-127, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559859
6.
Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides.
Acta Derm Venereol
; 100(13): adv00187, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128597
7.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 19(9): 1192-1204, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100375
8.
Factors contributing to time to chemotherapy, immunotherapy and radiation for patients with mycosis fungoides in the United States National Cancer Database.
Br J Dermatol
; 188(2): 299-301, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763861
9.
Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T-cell Lymphoma.
J Am Acad Dermatol
; 88(3): 680-683, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863465
10.
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.
Mod Pathol
; 30(5): 761-772, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128277
11.
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.
Blood
; 126(12): 1452-61, 2015 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26228486
12.
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoides.
J Cutan Pathol
; 44(5): 462-466, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28083948
13.
Usage and safety of topical tacrolimus in patients with mycosis fungoides.
Clin Exp Dermatol
; 47(6): 1200-1201, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245947
14.
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.
Acta Derm Venereol
; 96(7): 894-898, 2016 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001482
15.
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.
Clin Immunol
; 158(1): 1-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762519
16.
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
Cancer
; 120(16): 2464-71, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771533
17.
Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma.
Curr Opin Oncol
; 26(2): 237-44, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24441505
18.
Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas.
Hell J Nucl Med
; 17(2): 78-84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997076
19.
Immunobiology and treatment of cutaneous T-cell lymphoma.
Expert Rev Clin Immunol
; : 1-12, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450476
20.
Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.
J Am Acad Dermatol
; 68(6): 972-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23415461